Figure 6From: Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study Effect of TACE on serum VEGF levels. Fold-change in VEGF levels over time are depicted for observation and bevacizumab arms. One-sided t-test values for each timepoint are as follows: 1 h, 0.053; 24 h, 0.167; 48 h, 0.161; 72 h, 0.048; 360 h, 0.039; 528 h, 0.063; 696 h, 0.06Back to article page